Citation & Authors
Epilepsia. 2026;.
ABSTRACT · RESEARCH SUMMARY
Research summary
This matched Taiwanese National Health Insurance study found that SGLT2 inhibitors were associated with lower risks of seizures, epilepsy, and their composite than DPP-4 inhibitors. Compared with GLP-1 drugs, only the composite was significantly lower (aHR 0.66; p=0.016); individual outcomes were not significantly different. No significant differences were found between GLP-1 drugs and DPP-4 inhibitors.
Key points based on the public abstract; this is a reading guide, not a full abstract translation.Read original abstract ↗
